Search

everythinglearnresearchcommunity

for

Search:↓

2007 research improved understanding of prostate cancer risk, diagnosis, and treatment, but also showed the need for personalized treatment and further study on certain therapies' risks.

Keratin 18 helps diagnose and predict cancer progression and affects cancer growth and spread.

Hair transplant is effective for treating hair loss caused by radiation and improves patients' quality of life.

Sorafenib helps some advanced cancers alone or with other treatments, but not all, and research continues to improve its use.

High-dose vitamin A was safe and well-tolerated in a lung cancer treatment study.

The document provides advice on how to recognize and treat skin-related side effects of cancer drugs known as EGFR inhibitors.

The hair keratin gene KRT81 is found in both normal and breast cancer cells and helps them invade surrounding tissues.

Scalp cooling can prevent hair loss in 65% of chemotherapy patients, especially effective in breast cancer patients and certain chemotherapy types.

Low Vitamin D receptor levels in breast cancer are linked to worse outcomes and more bone metastases, and could be a marker for prognosis.

Cancer survivors often experience worse skin problems from treatment than expected, and working with dermatologists could help improve their condition.

Lacking cyclin D3 reduces skin cancer growth without affecting normal skin cell growth.

Milia may come from the outer part of the hair follicle.

Chemotherapy in the first trimester of pregnancy is risky, but in the second and third trimesters, it's generally safe with careful drug selection and timing.

Taking selenium supplements during chemotherapy may help reduce side effects and improve health markers in ovarian cancer patients.

Non-hormonal treatments should be used first for sexual dysfunction in postmenopausal breast cancer patients on aromatase inhibitors, with hormones as a second option.

Taking 1 mg/day finasteride for hair loss significantly lowers PSA levels in men, which may affect prostate cancer screening.

Adverse events from vismodegib can be managed effectively to ensure optimal treatment.

Suppressing certain hormones might help prevent prostate cancer.

Orlistat might block the body's ability to absorb thyroid medication.

Hippocampus sparing whole brain radiation therapy prevents hair loss and preserves cognitive function.

EGFR cancer drugs often cause a rash, which can lead to distress and isolation, but may also improve outcomes for some cancer patients. Current treatments for the rash are limited, but a compound called menadione shows promise.

Finasteride does not prevent bladder cancer.

Men with male pattern baldness have a higher risk of aggressive prostate cancer and benign prostatic hyperplasia.

Certain genetic variants increase the risk of resistance to hormone therapy in prostate cancer patients.

Scalp cooling is the only FDA-approved method to prevent hair loss from chemotherapy, but other treatments like minoxidil and PRP are being tested.

Some cancer treatments can cause abnormal fine hair growth.

Scalp hypothermia can prevent chemotherapy-induced hair loss but is not suitable for all patients, and more research is needed to improve prevention methods.

Finasteride significantly reduces PSA levels in men, and doctors should adjust PSA readings for those taking the drug.

A man's bald spot grew hair after starting cancer treatment with gefitinib.

Low-dose radiation therapy may improve brain function in some Alzheimer's patients and is generally well-tolerated.